RARA CRAFT DATABASE for FDA Medical Devices
510(k)K153410

FDA DEVICE FACTS

3M Tegaderm CHG Chlorhexidine Gluconate I.V. Securement Dressing

3M Company

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEMay 15, 2017PRODUCT CODESEL

Indications for use

The Intended Use of the subject and predicate devices is that they are antimicrobial dressings with CHG, used at catheter insertion sites. Indications for Use of the subject and the predicate devices are set forth in detail in the table directly below.

3M™ Tegaderm™ CHG Chlorhexidine Gluconate I.V. Securement Dressing (Submission Subject, K153410)

BIOPATCH Antimicrobial Dressing

(K003229) 3M™ Tegaderm™ CHG Chlorhexidine Gluconate I.V. Securement Dressing

(K063458, K080620) 3M™ Tegaderm™ CHG Chlorhexidine Gluconate I.V. Securement Dressing can be used to cover and protect catheter sites and to secure devices to skin. Common applications include I.V. catheters, other intravascular catheters and percutaneous devices.

Tegaderm™ CHG Chlorhexidine Gluconate I.V. Securement Dressing is intended to reduce vascular catheter colonization and catheter-related bloodstream infections (CRBSI) in patients with central venous or arterial catheters.

BIOPATCH containing Chlorhexidine Gluconate is intended for use as a hydrophilic wound dressing that is used to absorb exudate and to cover a wound caused by the use of vascular and non-vascular percutaneous medical devices such as: IV catheters, central venous lines, arterial catheters, dialysis catheters peripherally inserted coronary catheters, mid-line catheters, drains, chest tubes, externally placed orthopedic pins, and epidural catheters. It is also intended to reduce local infections, catheter-related blood stream infections (CRBSI), and skin colonization of microorganisms commonly related to CRBSI, in patients with central venous or arterial catheters. 3M™ Tegaderm™ CHG Dressings (Chlorhexidine Gluconate I.V. Securement Dressing) can be used to cover and protect catheter sites and to secure devices to skin. Common applications include IV catheters, other intravascular catheters and percutaneous devices.

The indications for use statement is different between the subject device and the predicate device. Specifically, the subject device indications for use includes an indication expansion “to reduce vascular catheter colonization and catheter-related bloodstream infections (CRBSI) in patients with central venous or arterial catheters.” This statement is not included in the predicate: 3M™ Tegaderm™ CHG Chlorhexidine Gluconate I.V. Securement Dressing. However, it pertains to a performance characteristic associated with the same intended use of being an antimicrobial dressing with CHG. To support this portion of the indications, 3M has provided performance data to show that the Tegaderm™ CHG I.V. Securement Dressings perform as claimed. 3M Company 3M™ Tegaderm™ CHG Chlorhexidine Gluconate Dressings In addition, the indications for use statement is different between the Tegaderm™ CHG I.V. Securement Dressing and the BIOPATCH Antimicrobial Dressing predicate. The Tegaderm™ CHG I.V. Securement Dressing indication expansion “to reduce vascular catheter colonization and catheter-related bloodstream infections (CRBSI) in patients with central venous or arterial catheters” is similar to BIOPATCH’s indication “to reduce local infections, catheter-related blood stream infections (CRBSI), and skin colonization of microorganisms commonly related to CRBSI, in patients with central venous or arterial catheters,” The differences in the Indications do not affect the safety and effectiveness of the device, and again, as stated above, do not alter the intended therapeutic, diagnostic, prosthetic, or surgical use of the subject device.

Technology Comparison The Tegaderm™ CHG I.V. Securement Dressing and the BIOPATCH Antimicrobial Dressing have similar technological characteristics. Both devices contain the same antimicrobial, chlorhexidine gluconate (CHG). The minor differences in technological characteristics do not raise different questions of safety or effectiveness, as confirmed by the testing activities described in this submission. Characteristic 3M™ Tegaderm™ CHG I.V Securement Dressing

(Submission Subject, K153410)

BIOPATCH Antimicrobial Dressing

(K003229)

3M™ Tegaderm™ CHG Chlorhexidine Gluconate I.V. Securement Dressing

(K063458, K080620)

Antimicrobial agent CHG Chlorhexidine Gluconate (CHG) Gel pad contains 2% w/w chlorhexidine gluconate

CHG Chlorhexidine Gluconate (CHG) contains chlorhexidine gluconate

(no subsequent 510k filings) CHG Chlorhexidine Gluconate (CHG) Gel pad contains 2% w/w chlorhexidine gluconate (unchanged from original 510k clearance) Dressing configuration

The Chlorhexidine Gluconate I.V. Securement Dressing consists of a transparent, semi-permeable adhesive dressing and an integrated hydrophilic gel pad containing 2% w/w Chlorhexidine Gluconate (CHG). A hydrophilic polyurethane absorptive foam with Chlorhexidine Gluconate (CHG). A separate unspecified dressing cover is needed. The Chlorhexidine Gluconate I.V. Securement Dressing consists of a transparent adhesive dressing and an integrated hydrophilic gel pad containing 2% w/w Chlorhexidine Gluconate (CHG). Absorbent Yes Yes Yes Transparent Yes N/A (opaque) Yes Breathable Yes Yes Yes 3M Company 3M™ Tegaderm™ CHG Chlorhexidine Gluconate Dressings Characteristic 3M™ Tegaderm™ CHG I.V Securement Dressing

(Submission Subject, K153410)

BIOPATCH Antimicrobial Dressing

(K003229)

3M™ Tegaderm™ CHG Chlorhexidine Gluconate I.V. Securement Dressing

(K063458, K080620) Broad spectrum, continuous, antimicrobial / Broad spectrum antifungal Yes Yes Yes 3M Company 3M™ Tegaderm™ CHG Chlorhexidine Gluconate Dressings

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 29, 2026